secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2024-10-22T23:59:59+00:00
Accession:  0001628280-24-043281
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q3 net sales $200M (-6% YoY); cuts FY2024 EPS guidance to $2.45
---------------------------------------------------------------------

- Q3 diluted EPS $0.56 vs $0.59 YoY; net sales down 6% to $200M.
- Active customers fell 3% YoY to 452,000; Greater China customers rose 6% but sales -4%.
- FY2024 outlook narrowed: net sales ~$850M (from $850-880M), EPS $2.45 (from $2.40-2.55).
- Balance sheet: $365M cash, debt-free; no shares repurchased in Q3.
- Regional weakness: North Asia -15%, Americas & Europe -7% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000162828024043281/0001628280-24-043281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000162828024043281/usna-20241022.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-043281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer